$2.6
Ibio is a biotechnology business based in the US. Ibio shares (IBIO) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $2.87 – an increase of 9.13% over the previous week. Ibio employs 16 staff and has a trailing 12-month revenue of around $225,000.
Our top picks for where to buy Ibio stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Ibio stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – IBIO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Ibio stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Ibio stock price (NYSE MKT: IBIO)
Use our graph to track the performance of IBIO stocks over time.Ibio shares at a glance
Latest market close | $2.87 |
---|---|
52-week range | $1.02 - $6.47 |
50-day moving average | $2.07 |
200-day moving average | $1.85 |
Wall St. target price | $4.30 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-4.03 |
Is it a good time to buy Ibio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Ibio price performance over time
Historical closes compared with the close of $2.87 from 2024-10-18
1 week (2024-10-11) | 9.13% |
---|---|
1 month (2024-09-20) | 45.69% |
3 months (2024-07-19) | 33.49% |
6 months (2024-04-19) | 66.86% |
1 year (2023-10-20) | 825.81% |
---|---|
2 years (2022-10-16) | N/A |
3 years (2021-10-20) | 227.59% |
5 years (2019-10-18) | 451.39% |
Ibio financials
Revenue TTM | $225,000 |
---|---|
Gross profit TTM | $2.2 million |
Return on assets TTM | -29.73% |
Return on equity TTM | -84.15% |
Profit margin | 0% |
Book value | $2.47 |
Market Capitalization | $26.2 million |
TTM: trailing 12 months
Ibio share dividends
We're not expecting Ibio to pay a dividend over the next 12 months.
Have Ibio's shares ever split?
Ibio's shares were split on a 1:20 basis on 28 November 2023 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ibio shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Ibio shares which in turn could have impacted Ibio's share price.
Ibio share price volatility
Over the last 12 months, Ibio's shares have ranged in value from as little as $1.0214 up to $6.468. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Ibio's is -3.411. This would suggest that Ibio's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Ibio has bucked the trend.
Ibio overview
iBio, Inc. , a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and trophoblast cell surface antigen 2, a monoclonal antibodies, as well as MUC16 and Target 5 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. iBio, Inc.
Frequently asked questions
nullWhat percentage of Ibio is owned by insiders or institutions?
Currently 0.142% of Ibio shares are held by insiders and 31.662% by institutions. How many people work for Ibio?
Latest data suggests 16 work at Ibio. When does the fiscal year end for Ibio?
Ibio's fiscal year ends in June. Where is Ibio based?
Ibio's address is: 11750 Sorrento Valley Road, San Diego, CA, United States, 92121 What is Ibio's ISIN number?
Ibio's international securities identification number is: US4510332038 What is Ibio's CUSIP number?
Ibio's Committee on Uniform Securities Identification Procedures number is: 451033203
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question